✦ LIBER ✦

Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01

✍ Scribed by Seock-Ah Im; Keun Seok Lee; Jungsil Ro; Eun Sook Lee; Youngmee Kwon; Jin-Hee Ahn; Jin Seok Ahn; Jee Hyun Kim; Han Sung Kang; Kyung Hwan Shin; Dong-Young Noh; In-Ae Park; Sung-Bae Kim; Young Hyuck Im; Sung Whan Ha

Book ID: 113062333
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 338 KB
Volume: 132
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1852-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RC0639: phase II study of paclitaxel, tr

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

✍ Alvaro Moreno-Aspitia,Amylou C. Dueck… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 312 KB

A phase Ib study of preoperative lapatin

A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer

✍ In Hae Park, Keun Seok Lee, Han-Sung Kang, Seok Won Kim, Seeyoun Lee, So-Youn Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 158 KB

Phase II Trial of Neoadjuvant Weekly Nan

Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer

✍ Mrózek, Ewa; Layman, Rachel; Ramaswamy, Bhuvaneswari; Lustberg, Maryam; Vecchion 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 292 KB

Phase II study of preoperative systemic

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer

✍ Masataka Sawaki; Hiroji Iwata; Yasuyuki Sato; Masaki Wada; Tatsuya Toyama; Eiich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Phase II Trial of Weekly Docetaxel, Vino

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; C 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

Phase II Interventional Study (N0337) of

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial

✍ Winston W. Tan; Jacob B. Allred; Muhammad Salim; Patrick Flynn; Paul A.S. Fishki 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB